N

NEUVOGEN

0 followers

NEUVOGEN is applying a systems biology approach to develop whole-cell therapeutic cancer vaccines.

Employees

51-200

Links


Org chart

Todd Binder
CEO & Board Member

Todd Binder

Collapse
Mark Backer
Head, Technical Operations
Peter Watler
Head, Manufacturing Operations
Bernadette Ferraro
VP, Immuno-Oncology
Dan Wilkinson
Head, Laboratory Department

Board & advisors